Home › Funds › Achmea Investment Management B.V. › DGX

Achmea Investment Management B.V. position in DGX

QUEST DIAGNOSTICS INC · Health Care

Achmea Investment Management B.V. reported holding 124,786 shares of DGX (QUEST DIAGNOSTICS INC) in its Q2 2026 13F filing — a position valued at US$26.4M, representing 0.66% of its reported portfolio and ranking #43 among its reported holdings. Achmea Investment Management B.V. has disclosed DGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)124.79K sh
Reported value held$26.45M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Achmea Investment Management B.V.'s DGX position evolved

Achmea Investment Management B.V. first disclosed a stake in DGX in Q3 2023 at 35,594 shares (US$4.3M). The position peaked in Q3 2025 at 144,209 shares, worth US$27.5M. Across 12 filings, Achmea Investment Management B.V. increased the stake 4 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 124,786 shares valued at US$26.4M — a reduction of -12,333 shares quarter over quarter.. Notable position changes include a 79% trim in Q1 2024 (shares rose 3% over the following quarter), a 652% increase in Q3 2024 (shares fell 3% over the following quarter), a 115% increase in Q4 2024 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 35.59K $4.34M New
Q4 2023 34.53K $4.76M Reduce
Q1 2024 7.23K $963.00K Reduce
Q2 2024 8.54K $1.17M Add
Q3 2024 64.28K $9.98M Add
Q4 2024 138.15K $20.84M Add
Q1 2025 136.47K $23.09M Reduce
Q2 2025 137.03K $24.61M Hold
Q3 2025 144.21K $27.48M Add
Q4 2025 137.99K $23.95M Reduce
Q1 2026 137.12K $26.87M Reduce
Q2 2026 124.79K $26.45M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About DGX and 13F data

DGX (QUEST DIAGNOSTICS INC) is a Health Care company. 31 other funds we track also report a position in DGX — the largest reported positions include Boston Partners (US$1.00B), EdgePoint Investment Group Inc. (US$476.4M), Grantham, Mayo, Van Otterloo & Co. LLC (US$400.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding DGX

All DGX fund holders →

FAQ

How long has Achmea Investment Management B.V. held DGX?

Achmea Investment Management B.V. has disclosed DGX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Achmea Investment Management B.V.'s current position in DGX?

As of Q2 2026, Achmea Investment Management B.V. holds 124.79K shares of DGX (QUEST DIAGNOSTICS INC), valued at $26.45M, representing 0.66% of its reported portfolio and ranking #43.

Has Achmea Investment Management B.V. been buying or selling DGX?

In the latest 13F filing (Q2 2026), Achmea Investment Management B.V. reduced its position in DGX. The position peaked in Q3 2025 at 144.21K shares.

Which other funds hold DGX?

Other major institutional holders of DGX include Boston Partners, EdgePoint Investment Group Inc., Grantham, Mayo, Van Otterloo & Co. LLC, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.